Current Issue Volume XVI, Issue 2, Winter 2010 Letter from the Editor (.html) Introduction (contains Table of Contents, Letter from the Editor, and Masthead)
4. The Regulation of Nanomedicine: Will the Existing Regulatory Scheme of the FDA Suffice? By: Shanna Harris
5. Will the Federal Circuit’s Eli Lilly v. Teva Decision Lead to Efforts to Abuse the Modification Provision of the Hatch-Waxman Act? By: Claire K. Comfort
6. Dreadful Policing: Are the Semiconductor Industry Giants Content with Yesterday’s International Protection for Integrated Circuits? By: Michael Fuerch
7. Students’ Free Speech Rights Shed at the Cyber Gate By: Vivian Lei
